AlphaYouGM
Insider buying
Ghiath M. Sukhtian bought $2.5M of Outlook Therapeutics, Inc. (OTLK) stock
Ghiath M. Sukhtian, Dir, 10% of Outlook Therapeutics, Inc. (OTLK), bought 2,525,252 shares of OTLK stock worth $2.5M, per an SEC Form 4 filed Aug 14, 2026.
The shares came through a private deal, not the open market.
The trade happened on Aug 12, 2026, 2 days before it was made public.
OTLK has moved -37.6% since the trade date, from $1.10 to $0.69 (Sep 21, 2026 close).
- Traded
- Aug 12, 2026
- Disclosed
- Aug 14, 2026
- Filing delay
- 2 days
- Price since
- -37.6%
- Role
- Dir, 10%
- Source
- SEC Form 4
More OTLK insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.